Cannabis compounds could reverse disease affecting one-third of adults
Recent research suggests that cannabinnoids from cannabis may offer new treatment options for the prevalent liver disorder known as MASLD.
People with overweight or obesity and type 2 diabetes are at greater risk of fatty liver, according to studies
Research indicates that individuals with overweight, obesity, and type 2 diabetes have a significantly higher risk of developing fatty liver disease, particularly the non-alcoholic form known as MASLD.